2 hours ago
1
jetcityimage/iStock Editorial via Getty Images
Eli Lilly (NYSE:LLY) must pay $183.7M as damages in a lawsuit alleging that the Indiana-based drugmaker defrauded the Medicaid drug pricing program, a federal appeals court ruled on Thursday, upholding a lower court ruling.
In August 2022, a federal jury ordered
© FBT Company 2025. All rights are reserved
English (US) ·